Assess whether related-party sales should be backed out of valuation (a56a4d)

SITUATION A family-office reviewing a manufacturing target cannot treat a QoE that cannot tie revenue to bank cash as incidental context on management-team retention and key-person map. Customer-contract risk reviewer must close related-party sales should be from that extract under M&A Due Diligence / Legal, IP, and Regulatory.

DECISION Customer-contract risk reviewer in a family-office reviewing a manufacturing target must choose Proceed / Reprice / Walk / Hold using management-team retention and key-person map after a QoE that cannot tie revenue to bank cash.

HYPOTHESES TO TEST 1. Customer-contract risk reviewer can defend Proceed from management-team retention and key-person map after a QoE that cannot tie revenue to bank cash in a M&A Due Diligence challenge. 2. Customer-contract risk reviewer cannot defend Proceed from management-team retention and key-person map; Reprice is what the extract actually supports after a QoE that cannot tie revenue to bank cash. 3. A QoE that cannot tie revenue to bank cash never reached the population in management-team retention and key-person map — reopen intake, do not close related-party sales should be. 4. Two facts in management-team retention and key-person map after a QoE that cannot tie revenue to bank cash conflict for customer-contract risk reviewer; hold this Legal, IP, and Regulatory file.

ANALYSIS REQUIRED 1. Map reps, earnout mechanics, and integration risk a family-office reviewing a manufacturing target would inherit. 2. Tie quality-of-earnings, working-capital, and contingent items in management-team retention and key-person map to related-party sales should be. 3. Name the document customer-contract risk reviewer still needs before signing. 4. For this M&A Due Diligence Legal, IP, and Regulatory file, read management-team retention and key-person map against a QoE that cannot tie revenue to bank cash and write the one fact that would move related-party sales should be for customer-contract risk reviewer.

RECOMMENDATION Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Legal, IP, and Regulatory packet (management-team retention and key-person map after a QoE that cannot tie revenue to bank cash). If management-team retention and key-person map cannot force a M&A Due Diligence label under Legal, IP, and Regulatory, stop. If management-team retention and key-person map after a QoE that cannot tie revenue to bank cash cannot support Proceed versus Reprice on this M&A Due Diligence Legal, IP, and Regulatory close, customer-contract risk reviewer must do not proceed, reprice, or walk on a quality-of-earnings fact the packet does not carry.

COMMAND RETURNS - Bottom-line M&A Due Diligence option on related-party sales should be, then the evidence in management-team retention and key-person map, then the action for customer-contract risk reviewer - Hypothesis scorecard against management-team retention and key-person map: supported / rejected / untestable - Missing page in management-team retention and key-person map after a QoE that cannot tie revenue to bank cash, if any - Regulatory or exam hook Legal, IP, and Regulatory would cite